Clinical Trials on Obesity, Childhood in Japan
Total 58 results
-
Kyoto UniversityWithdrawnLocalized Resectable Adult Primary Liver Cancer | Stage III Childhood Liver CancerJapan
-
Hiroshima UniversityBiostir, Inc.; MIONA Co., Ltd.Completed
-
Novo Nordisk A/SCompleted
-
Hiroshima UniversityUnitika Ltd.Completed
-
SanofiTerminated
-
Novo Nordisk A/SNot yet recruiting
-
Eli Lilly and CompanyRecruiting
-
Kagoshima UniversityUnknown
-
SanofiTerminatedObesity | Diabetes Mellitus Type 2Japan
-
SanofiTerminatedObesity | Diabetes Mellitus Type 2Japan
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
-
Wafaa Mahmoud AminCairo UniversityCompletedOverweight and Obesity | Balance; DistortedSaudi Arabia
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
University of JazanCompletedCoronary Artery Disease | ObesitySaudi Arabia
-
Wafaa Mahmoud AminCairo UniversityCompletedOverweight and Obesity | Motor Activity | Hand InjuriesSaudi Arabia
-
Eli Lilly and CompanyActive, not recruiting
-
Novartis Gene TherapiesPRA Health SciencesCompletedSpinal Muscular Atrophy Type IKorea, Republic of, Taiwan, Japan
-
Rhythm Pharmaceuticals, Inc.Enrolling by invitationHypothalamic ObesityUnited States, Canada, Japan, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyCompleted
-
University of JazanRecruitingObesity | Body Weight | Smartphone Addiction | Cervical Myofascial Pain SyndromeSaudi Arabia
-
Eisai LimitedCompleted
-
PfizerActive, not recruitingPrader-Willi SyndromeJapan
-
Bispebjerg HospitalWorld Health Organization; International Network of Health Promoting Hospitals... and other collaboratorsCompletedSmoking | Obesity | Malnutrition | Excessive Drinking | Lack of Physical ActivityCanada, Croatia, Czechia, Denmark, Estonia, Indonesia, Japan, Malaysia, Slovenia, Taiwan, Thailand
-
National Hospital Organization Nagoya Medical CenterRecruitingAcute Lymphoblastic Leukemia | Down Syndrome | Childhood CancerTaiwan, Thailand, Hong Kong, Singapore, Malaysia, Japan
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimRecruiting
-
Novo Nordisk A/SCompletedObesity | OverweightJapan, Korea, Republic of
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Overweight or ObesityUnited States, China, India, Taiwan, Japan, Brazil, Puerto Rico, Spain, Korea, Republic of, Slovakia
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
PfizerCompletedObesityUnited States, Taiwan, Canada, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
-
Novo Nordisk A/SRecruitingObesityUnited States, Australia, Japan
-
Novo Nordisk A/SRecruitingObesity | OverweightBrazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
-
Hoffmann-La RocheRecruitingChildhood Idiopathic Nephrotic SyndromeBelgium, United States, Poland, China, France, Spain, Japan, Brazil, Italy, Turkey
-
Boehringer IngelheimActive, not recruitingObesityUnited States, Korea, Republic of, Belgium, Australia, China, Poland, Japan, Finland, Germany, Canada, Netherlands, New Zealand, Sweden, United Kingdom
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Japan, Mexico, Brazil, Puerto Rico, Argentina, Russian Federation
-
Novartis Gene TherapiesActive, not recruitingSMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type IIIUnited States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland